ORANGE JUICE AND CANCER CHEMOPREVENTION
Rech Franke SI, Guecheva TN, Henriques JA, Prá D.
a PPG em Promoção da Saúde, Universidade de Santa Cruz do Sul , Santa Cruz do Sul, RS, Brasil.
Abstract
Orange juice (OJ) is among the most consumed fruit juices worldwide, and its chemopreventive action is fairly addressed in the literature. This review critically presents the available evidence linking OJ with cancer chemoprevention and on discussing the putative mechanisms and negative health effects. The chemopreventive action of OJ is related to its effect on metabolic enzymes and its anti-inflammatory, cytoprotective/apoptotic, hormonal, cell signaling-modulating, antioxidant, and antigenotoxic effects. Most studies on OJ are in vitro, and few are conducted in vivo. Results from in vitro studies must be interpreted carefully because these findings do not consider in vivo bioavailability. However, such results are useful for studying the impact of different processing and storage methods on OJ's chemopreventive effect. Evidence of OJ's chemoprevention in humans is limited. OJ is antimutagenic in bacteria and antigenotoxic in humans and rodents. Studies using rodent cancer models showed that OJ is cancer chemopreventive, influencing either the induction stage or the promotion stage. The composition and, therefore, the chemopreventive action of OJ might be influenced by different cultivars, climates, extraction methods, packaging, storage temperatures, and shelf lives, among other factors. Epidemiological studies and randomized controlled intervention studies in humans evaluating the chemopreventive effect of OJ, taking into consideration variability in OJ composition, are needed.
PubMed

STUDY SUGGESTS ANTIOXIDANT TREATMENT MAY HELP NF1-LINKED BEHAVIORAL ISSUES
New research in mouse models suggests that treatment with antioxidants may help reduce behavioural issues linked to the genetic nervous system disorder Neurofibromatosis 1 (NF1) and an associated condition called Costello syndrome. Scientists from Cincinnati Children’s Hospital Medical Centre report their findings Sept. 12 in Cell Reports. The authors show that defects in the NF1/Ras molecular pathway, which cause the disorders, trigger production of harmful oxidative nitric oxide molecules in the oligodendrocyte glial brain cells of mice.
Part of the central nervous system, glial cells produce a substance called myelin, which provides a sheath along nerves that acts as a form of electrical insulation. Increased production of nitric oxide in the tested mice disrupted the tight structure of proteins and related components that make up the myelin sheath. It also damaged vasculature surrounding astrocyte cells and endothelial tissue. Altogether, these changes altered the permeability of the blood brain barrier. According to researchers, affected mice had enlarged mutant white brain matter, enlarged optic nerves and exhibited hyperactive behaviour. Levels of nitric oxide synthases (an enzyme that causes production nitric oxide) were significantly up-regulated in the mutant white matter.
Hyperactivity is present in up to 60 percent of people with NF1or a Rasopathy like Costello syndrome. A Rasopathy is a condition fuelled by disruptions in the Ras molecular pathway. In their study, the authors tested mice bred to model both human NF1 and Costello syndrome.
“Our data provide a potential cellular and molecular mechanism of Rasopathy brain abnormalities, and we show that treatment with a broad spectrum antioxidant reverses the disruption of affected tissues and improves hyperactive behaviour,” said Nancy Ratner, PhD, senior investigator and a researcher in the Division of Experimental Hematology/Cancer Biology at Cincinnati Children’s. “It will be interesting to see if people with Rasopathy exhibit the same white matter enlargement and cellular features we identified in our laboratory tests.”
To treat the mice, researchers used a broad spectrum antioxidant called NAC, or N-Acetyl Cysteine, in the animals’ drinking water. After six weeks of exposure to NAC, both the mouse models of NF1 and Costello syndrome improved. Abnormal cellular and tissue structure were reversed and hyperactive behaviour subsided, according to researchers. The reversal of symptoms was more pronounced in the Costello animals than the NF1 animals.
The authors said they induced the structural deficiencies in the oligodendrocytes of both immature and mature adult mice. In both instances, researchers were able to use NAC treatment to reverse symptoms during adulthood, suggesting the brain defects are not linked to early life developmental processes.
When researchers gave the same antioxidant treatment to normal wild type mice, it caused the blood brain barrier to open and harmed the compact structure of myelin. Researchers said this shows high levels of antioxidant treatment in animals without elevated reactive oxygen levels can be detrimental.
People with NF1 can suffer from a number of cognitive and behavioural deficits and the current study sheds important new light on molecular processes that may drive these deficits. At the same time, authors cautioned that laboratory studies involving mouse models do not necessarily translate to treatment of human disease and additional study is needed.
A key collaborator in the study was first author Debra Mayes, PhD, a research fellow in the Ratner laboratory. Funding support for the study came from the DAMD Program on Neurofibromatosis, a Drug Discovery Initiative Award from the Children’s Tumor Foundation, the National Institutes of Health (T32CA117846) and the National Multiple Sclerosis Society.
www.cincinnatichildrens.org

TOXIC NANOPARTICLES MIGHT BE ENTERING HUMAN FOOD SUPPLY
Scientists develop new way to detect threatening nanoparticles in food
Over the last few years, the use of nanomaterials for water treatment, food packaging, pesticides, cosmetics and other industries has increased. For example, farmers have used silver nanoparticles as a pesticide because of their capability to suppress the growth of harmful organisms. However, a growing concern is that these particles could pose a potential health risk to humans and the environment. In a new study, researchers at the University of Missouri have developed a reliable method for detecting silver nanoparticles in fresh produce and other food products.

"More than 1,000 products on the market are nanotechnology-based products," said Mengshi Lin, associate professor of food science in the MU College of Agriculture, Food and Natural Resources. "This is a concern because we do not know the toxicity of the nanoparticles. Our goal is to detect, identify and quantify these nanoparticles in food and food products and study their toxicity as soon as possible."
Lin and his colleagues, including MU scientists Azlin Mustapha and Bongkosh Vardhanabhuti, studied the residue and penetration of silver nanoparticles on pear skin. First, the scientists immersed the pears in a silver nanoparticle solution similar to pesticide application. The pears were then washed and rinsed repeatedly. Results showed that four days after the treatment and rinsing, silver nanoparticles were still attached to the skin, and the smaller particles were able to penetrate the skin and reach the pear pulp.
"The penetration of silver nanoparticles is dangerous to consumers because they have the ability to relocate in the human body after digestion," Lin said. "Therefore, smaller nanoparticles may be more harmful to consumers than larger counterparts."
When ingested, nanoparticles pass into the blood and lymph system, circulate through the body and reach potentially sensitive sites such as the spleen, brain, liver and heart.
The growing trend to use other types of nanoparticles has revolutionized the food industry by enhancing flavours, improving supplement delivery, keeping food fresh longer and brightening the colours of food. However, researchers worry that the use of silver nanoparticles could harm the human body.
"This study provides a promising approach for detecting the contamination of silver nanoparticles in food crops or other agricultural products," Lin said.
Members of Lin's research team also included Zhong Zang, a food science graduate student. The study was published in the Journal of Agricultural and Food Chemistry.
University of Missouri-Columbia

DIETS LOW IN POLYUNSATURATED FATTY ACIDS MAY BE A PROBLEM FOR YOUNGSTERS
In the first study to closely examine the polyunsaturated fatty acid (PUFA) intake among U.S. children under the age of 5, Sarah Keim, PhD, principal investigator in the Center for Biobehavioral Health at The Research Institute at Nationwide Children’s Hospital, has found what might be a troubling deficit in the diet of many youngsters. The study, published online by Maternal and Child Nutrition, used data on nearly 2500 children age 12 to 60 months from the U.S. National Health and Nutrition Examination Survey.
PUFAs are essential to human health. A proper ratio of omega-6 to omega-3 PUFAs plays an important role in cell function, inflammation, eye development and neural functioning. However, the ideal dietary intake of PUFAs for young children is unclear. Knowing that infants often receive significant amounts of key PUFAs through breast milk and infant formula during the first year of life, Dr. Keim and her colleague, Amy Branum, PhD, MSPH, of the Centers for Disease Control and Prevention, decided to estimate the average intake of PUFAs in the diet for children between infancy and kindergarten.
“The ratio of omega-6 to omega-3 intake was high—about 10. Some experts use this as an indicator of diet quality, with a high ratio being less healthy,” says Dr. Keim. “In addition, intake of a key fatty acid known as DHA in children 12 to 60 months of age was low—lower than what infants generally consume—and it did not increase with age.”
Dr. Keim’s study was also the first to examine the primary dietary sources of PUFA intake among children under the age of 5 and to examine age, race and ethnicity in relation to fish intake in this age group. Fish are an excellent source of fatty acids, such as DHA and EPA, and were shown to be the richest sources of PUFAs in children’s diets.
“Only about 54 percent of children ate fish at least once in the previous month. Non-Hispanic black children were more likely than non-Hispanic white children to have eaten fish,” says Dr. Keim. “Because diet can be an important contributor to many diseases, it’s important to understand how such disparities might contribute to disease risk.”
The swift physical and neurological development during this period of childhood may mean that variations in PUFA intake could have important implications for growth, she adds.
“This work could help inform dietary recommendations for children, and may be particularly important for the preterm population,” Dr. Keim says. “We are currently carrying out a clinical trial to see if DHA supplementation when children are 1 year of age can help cognitive development in those born preterm.”
At present, there is no official dietary recommendation in the U.S. for DHA and EPA intake or supplementation among children, although the Institute of Medicine has issued what they call a “reasonable intake” level of two 3-oz servings of fish per week for children. “According to our research, however, children are clearly not consuming this much fish,” says Dr. Keim. In addition, the researchers found that overall intake of key fatty acids, such as DHA and EPA, among U.S. children is only a fraction of what is regularly consumed by young children in certain other countries, including Canada. Other studies suggest that similarly low intakes exist in kids age 5 and older. By incorporating key omega-3 PUFAs into a child’s diet at a very early age, Dr. Keim says, it may be more likely to become part of a lifelong diet.
Dr. Keim hopes her work will contribute to a more detailed understanding of the diets of young children in the U.S. and will motivate health professionals to start considering the specific nutritional needs of children for healthy growth and development. “We’d like to continue our work examining dietary patterns in very young children, since they are often excluded from dietary studies,” she says.
Ideally, Dr. Keim says she would like to see families expose their children to a variety of fresh foods as soon as they are old enough to eat solids. “Dietary habits can form very early, so starting with a balanced diet may have long-lasting effects for children’s health.” According to Dr. Keim, this balanced diet should include fish and other good sources of healthy fatty acids.
www.nationwidechildrens.org

NEW STUDY INFORMS BLUEBERRY FLAVOUR SELECTION
Changes in volatile compounds, eating quality of berries correlated
The University of Florida's (UF) Blueberry Breeding Program has been developing successful blueberry cultivars for more than 60 years. The cultivars released from UF are credited with creating a Florida blueberry industry that was valued at $48 million in 2010, and allowing rapid expansion of blueberry production in other subtropical areas of the world. In the past, blueberry flavour selection in the program was based on two standards: subjective ratings from breeders, and a berry's sugar-to-acid ratio. Recently, scientists have determined that the "eating quality" of blueberries has a much higher correlation to consumer acceptance and indication of "blueberry-like flavour intensity" than the traditional measures of sweetness, acidity, or sugar/acid ratios.
Identifying blueberry volatile components that correspond to the fruity, intense, sweet, and characteristic blueberry flavours could help blueberry breeders select for cultivars that produce a more desirable flavour. A new research study from University of Florida Institute for Plant Innovation scientists Jessica Gilbert, Michael Schwieterman, Thomas Colquhoun, David Clark, and James W. Olmstead (HortScience, July 2013) sought to measure the characteristics associated with the "blueberry eating experience" by prioritizing the traits that could help improve flavour.
The study compared volatile profiles of five southern highbush blueberry cultivars (Farthing, FL01-173, Scintilla, Star, and Sweetcrisp) using gas chromatography–mass spectrometry. "These five cultivars are significant in Florida and have been subjectively rated as having varied flavour characteristics," noted lead author James Olmstead. The research team harvested all five cultivars on four separate dates during the harvest season, and fruit from each cultivar were also harvested at four developmental stages on the first harvest date. As expected, total volatiles showed dramatic increases as ripening progressed. 'Star' had the smallest statistical variation in volatile content over the 4-week harvest period, whereas 'Scintilla' had the largest variation in volatile content. "We sought to profile the changes in volatiles through blueberry development. The general profile was an increase in total volatiles in blueberry samples as fruit progressed in maturity from green to blue," Olmstead explained.
The researchers noted that, when blueberries are commercially harvested when they are immature, they may contain low levels of many of volatile compounds, and therefore will not have the characteristic blueberry flavour. "If the volatiles in this study are in fact the most important to the perception of blueberry flavour, then 'Star' may have the most consistent flavour in response to varying environmental factors," they concluded.
American Society for Horticultural Science

ALGAEON INC. & VALENSA INTERNATIONAL
Algaeon Inc. has announced the signing of a multi-year, multi-million dollar supply agreement with Valensa International which provides high value “condition specific” nutraceuticals to the marketplace. Algaeon, in cooperation with Valensa, is using its extensive knowledge of algae production to bring a new level of efficiency and quality for algae-based ingredient supply to the nutraceutical market. Paul DeLacey Chairman & CEO, Algaeon Inc. explains: “Algaeon is thrilled to be working together with Valensa, a global leader in nutraceutical formulation for the human supplement market, and we are looking forward to bringing our exciting technology to the market […] We are confident that our combined strengths will allow us to move quickly and make a significant impact on the ‘condition specific’ nutraceutical market”.
www.algaeon-inc.com

INNOVATIVE BETA-CAROTENE COLOURANT
LycoRed Ltd. has developed new and innovative beta-carotene colourant formulations delivering high-intensity colouring. Lyc-O-BetaTM Intense and BetaCoteTM Intense deliver increased colour intensity allowing for lower colourant usage. The advantages of Lyc-O-Beta and BetaCote Intense include higher colour intensity than any other beta-carotene colourants on the market. They deliver a final product colour shade similar to competitive products. Additionally, compared to other technologies, these colours from LycoRed are extremely resistant to the fading that can occur as a result of pasteurisation and other stressful processes.
www.lycored.com

SABINSA ON WHEELS
“This is our premier scientific seminar event where Sabinsa showcases the latest and greatest science we have on our selected ingredients”, Shaheen Majeed, Marketing Director of Sabinsa, declared: “We have many speakers, on different topics and even guest speakers with their topic of choice”. The event was hold in several places around the globe. Last year it was in South Korea while this year it touched three major states in USA: Utah (September 17), California (September 19) and New Jersey (October 8). “Fun times, but also extremely busy for me, as I am coordinating everything. We recently had our Sr. VP of Sales & Marketing leave us, therefore increasing the workload on me, but that is ok, I am grateful to be busy at work always” continued Majeed. America's Finest, INC. is Sabinsa's finished line of dietary supplement products. Shaheen Majeed: “we have not focused on it in the past but I see the need for it as we mature into the marketplace. Our ingredients, sometimes on average takes 2 years before hitting it well in the marketplace. This is not due to a lack of science or tests, clearly Sabinsa has an advantage in those areas - it is also not due to the manufacturability of these new ingredients, as we own the manufacturing sites that we produce these ingredients in…so what is it? I see how the marketing companies work, and in most cases, it's going with the flow of the marketplace (e.g. if green tea is popular for weight loss, other marketing companies will jump on that, and not necessarily innovate and standout); all while, America's Finest (AFI) has the complete ability to be first in the marketplace with the latest and greatest of Sabinsa ingredients. There is a lot of work to be done in this area and it's one I am keen on”. Finally, speaking about Sabinsa Manufacturing (Payson, Utah Facility) Shaheen Majeed explained: “We are now NSF certified and my last couple of meetings where we met customers, they gave me great insight as to what they would like. This type of conversation happened, because the parties at the table had an open mind to business, wanted business to happen, was willing to open up and share the difficulties on both sides - and as I walked away from those meetings, I took with me some great insight to help both Sabinsa and our customers. Therefore, the work behind the contract manufacturing, from engaging clients on new projects to set them up on our private label business opportunities, all will strengthen in the very near future”.
www.sabinsa.com

BAG-IN-BOX
Alfa Laval has launched an aseptic beer-in-box filler plus an ultra-high-speed bag-in-box filler that is 4-5 times faster than standard aseptic fillers. Bag-in-box is a handy package that attracts more and more customers due to its various benefits: -Long storage time due to sterile filling and impermeable films, granting constant product quality; -Ideal for a wide variety of beverage and food products, dairy as well as non-dairy, including products with fibres, seeds and particulates due to the special filling via a plastic fitment; -Convenience and flexibility thanks to the variety of caps for one or multiple dispensing units including refrigerated (or heated) solutions.
www.alfalaval.com

LOW GLYCEMIC INDEX
Taura Natural Ingredients is going to showcase its low glycemic index URC^® fruit pieces highlighting the rich opportunities they offer for creating delicious snacks that provide slow release energy. The company refers that for JusFruit URC® Apple Strawberry and for JusFruit URC^® Mixed Berry the tests confirmed conclusively that both registered as low GI – a measure indicating that they release energy slowly into the bloodstream, which can help to keep hunger at bay and assist in controlling blood glucose levels.
www.tauraURC.com

SUSTAINABILITY COMMITTEE FOR NATUREX
Naturex has launched a comprehensive sustainability program covering every aspect of its activities. a dedicated sustainability committee is driving the entire program and has developed a specific set of sustainability principles for the company. Led by Serge Sabrier, member of the company’s management committee, the sustainability committee ensures that all aspects of day-to-day business operations and growth strategy are conducted in accordance with a set of principles explicitly set out by Naturex in support of Environmental Stewardship, Economic Prosperity, and Social Responsibility.
www.naturex.com

INDENA: US FDA INSPECTION
Indena announces that its French production site in Tours (France) successfully passed the US FDA inspection. The inspection involved the entire organization and focused on manufacturing operations, HACCP, sanification, cleaning, recall, complaint and training program and procedures. François Mairel, Indena Tours Plant Director explains: “We are pleased with the successful outcome of the FDA inspection - said – the audit covered the manufacturing of important products we are selling to our US customer base, like grape seed, olive polyphenolic and ginkgo biloba extracts and further confirms our commitment in giving our customers the highest standards of quality”.
www.indena.com

COCOA FLAVANOLS & ELASTICITY OF BLOOD VESSELS
Barry Callebaut has announced that the EU Commission approved its health claim submission on cocoa flavanols (Regulation No 851/2013), following the positive Scientific Opinion issued by the European Food Safety Authority (EFSA) in July 2012. The company received the right to use the health claim that "cocoa flavanols help maintain the elasticity of blood vessels, which contributes to normal blood flow" - the first in the cocoa and chocolate industry.
www.barry-callebaut.com

RINGIER TECHNOLOGY INNOVATION AWARD
Tate & Lyle is pleased to announce that its natural, no-calorie sweetener TASTEVA™ Stevia Sweetener was awarded the Ringier Technology Innovation Award in the Food & Beverage Industry (Flavourings) at the 15th Asian Food Ingredients China Exhibition held in late June in Shanghai. TASTEVA™ Stevia Sweetener, a versatile, clean tasting sweetener, is easy to formulate with and has shown in tests to be preferred by consumers offering a superior taste profile over RebA 97 and other stevia products. TASTEVA™ Stevia Sweetener, which was launched in March earlier this year at the Food Ingredients China 2013, further enhances Tate & Lyle’s extensive sweetener portfolio which includes SPLENDA® Sucralose, PUREFRUIT™ Monk Fruit Extract and a wide range of nutritive sweeteners.
www.tateandlyle.com

DSM ONCE AGAIN AMONG LEADERS IN DJ SUSTAINABILITY WORLD INDEX
Royal DSM, the global Life Sciences and Materials Sciences company, is once again amongst the leaders in the chemical industry sector in the Dow Jones Sustainability World Index published today. DSM launched some major ECO+ products in H1 2013. This increased the share of ECO+ solutions in its Innovation pipeline to 93 percent in H1 2013, which is above the 2015 aspiration of 80 percent. The share of ECO+ products in DSM’s running business portfolio was 41 percent in the first half of 2013, well on track towards the 2015 aspiration of 50 percent. Earlier this year DSM announced plans to help provide effective nutrition interventions to 50 million beneficiaries (pregnant or lactating women, children under the age of 2) per year by 2020.
www.dsm.com

LCMS-8050
Shimadzu will release the LCMS-8050, a triple quadrupole LCMS/MS. This new system incorporates proprietary ultrafast technologies as well as a newly developed ion source and collision cell technology. As the flagship model of Shimadzu’s UFMS (Ultra-Fast Mass Spectrometry) product line, the LCMS-8050 features high sensitivity, high data quality and the world’s fastest data acquisition rates.
www.shimadzu.eu

EXTRAMEL M: CONCENTRATED MELON JUICE MICROENCAPSULATED
Bionov presents EXTRAMEL M. They are concentrated melon juice microencapsulated in a vegetal coating. EXTRAMEL M are guaranteed for their Superoxide Dismutase (SOD) content. The microgranules also contain other ingredients which compose the antioxidant cocktail naturally found in the melon's pulp (catalase, glutathione, vitamins, caratenoids, selenium, etc…). EXTRAMEL M are available for human consumption as an active ingredient for nutritional supplements and functional foods.
www.bionov.com

SYMRISE BIOACTIVES AND GEE LAWSON
Symrise BioActives and Gee Lawson are extending a cooperation, which began in 2011. Symrise BioActives manufactures highly purified esculin, which Gee Lawson supplies to the diagnostics industry. Esculin is used in microbiology culture media to reliably identify contamination from spe-cies such as streptococci and listeria, and so can be used to monitor food and water as well as the clinical testing of patients. Symrise BioActives’/Gee Lawsons’ “Diagnostic Esculin” is approved by all of the leading diagnostics manufacturers. “With Gee Lawson as our partner, we can reach all of the major diagnostics customers” says Stephan Hillers, Managing Director of Symrise BioActives GmbH in Hamburg and refers: “Their market expertise and contact with culture media manufacturers perfectly complement Symrise BioActives’ experience in produc-ing highly enriched plant extracts”.
http://bioactives.symrise.com
www.geelawson.com

SECOND PRODUCTION LINE FOR REXAM BCSA
Rexam BCSA (Beverage Cans South America) will open its second production line in its plant of Santiago, Chile. With the expansion, the plant’s capacity will reach 1.9 billion cans per year in the second half of 2014. This will mean an increase of 72 percent in the plant’s current production volume. “This investment is crucial not only to consolidate Rexam’s position in the region but also to ratify our commitment to support our customers’ growth and to exceed consumers’ expectations" says Carlos Medeiros, Rexam’s Sector Director for South America.
www.rexam.com

PANTARÔME
CEMOI, the leading French chocolate maker has created an unprecedented sensory analysis tool for the cocoa world. Its name: «Pantarôme». This unique colour chart identifies the different aromatic notes perceived in a cocoa mass. It was created by CEMOI to help their professional customers such as industrialists, distributors and artisans with the conception of their chocolate recipes. With the help of this chart and advice from a CEMOI chocolate expert, customers can now better comprehend the cocoa associations proposed and identify their taste and aromatic combinations to create a more personalised chocolate.
www.cemoi.fr

ENERGY-EFFICIENT EVAPORATOR
NIZO food research has assisted FrieslandCampina DMV with the design of its unique energy-efficient evaporator. The newly installed evaporator cuts energy use by 60 percent. FrieslandCampina DMV in Veghel recently installed an energy-efficient evaporator that is the only one of its kind. It evaporates water from whey, allowing the lactose to crystallise spontaneously. By using smart technology, the current combination of mechanical and thermal evaporation techniques can be replaced by a single mechanical technique to cut energy consumption by an additional 60 percent. The heat released using this new technique is used so efficiently that cooling water is no longer needed. In the design phase of this new evaporator, NIZO food research worked together with DMV to determine the optimal configuration.
www.nizo.com

AB-FORTIS
AB-Fortis is a patented encapsulated iron system that provides the recommended daily amount of iron in a single dose, while avoiding the metallic taste and classic side effects of standard iron supplements, such as dental darkening, gastrointestinal upset or nausea. The encapsulated iron can be incorporated into fat-rich matrices, such as milk or yogurt, without causing oxidation. In addition, AB-Fortis resists high temperatures and can be included in formulations across any pH level. Frutarom Health and the AB-Biotics biotech company have signed an exclusive global Agency sale and marketing agreement (effective from July 1st 2013) for marketing AB-Fortis^®.
www.frutarom.com

FORTITECH SELECTIONS
Condition-specific products targeting a variety of health concerns will showcase Fortitech’s (now a part of DSM) ability to fortify any application with any nutrient during the next Worldwide events. Continuously setting the standard in the field of fortification with unparalleled expertise, Fortitech is solely dedicated to the development of custom nutrient premixes. With the capability to source over 1,400 ingredients from a comprehensive selection of vitamins, minerals, amino acids, nucleotides and nutraceuticals from around the world, their samples that will be on hand include: - Ice Cream Aiding In Bone and Joint Health; - Cupcakes Supporting Growth and Development; - Cheese Popcorn aiding in Children’s Health; - Relaxation Chocolate Bars; - Antioxidant Coffee; - Power Caps.
www.fortitech.com